Evidence map›Paper›PMID 31405046›Full record

ArticleBrain sciences2019

Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART.

Jaime H Vera, Margherita Bracchi, Jasmini Alagaratnam, Julianne Lwanga, Julie Fox, Alan Winston, Marta Boffito, Mark Nelson

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Risk factors for cognitive decline in persons with HIV.Current opinion in infectious diseases · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jaime H VeraDepartment of Global Health and Infection, Brighton and Sussex Medical School and Brighton and Sussex University Hospitals NHS Trust, London BN1 9PX, UK. J.Vera@bsms.ac.uk.
Margherita BracchiChelsea and Westminster NHS Foundation Trust, London SW10 9NH, UK.
Jasmini AlagaratnamImperial College London, St Mary's Campus, London W2 1PG, UK.
Julianne LwangaGuy's and St Thomas' NHS Trust, London SE1 7EH, UK.
Julie FoxGuy's and St Thomas' NHS Trust, London SE1 7EH, UK.
Alan WinstonImperial College London, St Mary's Campus, London W2 1PG, UK.
Marta BoffitoChelsea and Westminster NHS Foundation Trust, London SW10 9NH, UK.
Mark NelsonChelsea and Westminster NHS Foundation Trust, London SW10 9NH, UK.
Chelsea and Westminster Hospital NHS Foundation Trust · GBGuy's and St Thomas' NHS Foundation Trust · GBImperial College London · GBBrighton and Sussex Medical School · GB

Funding

Gilead Sciences IAG
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Central nervous systemefavirenzHIVrilpivirine

Identifiers

PMID31405046
PMCPMC6721293
OpenAlexW2968713186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.